Literature DB >> 26316759

Employment and the associated impact on quality of life in people diagnosed with schizophrenia.

Clazien Bouwmans1, Caroline de Sonneville1, Cornelis L Mulder2, Leona Hakkaart-van Roijen1.   

Abstract

A systematic review was conducted to assess the employment rate of people with schizophrenia. Additionally, information from the selected studies concerning factors associated with employment and health-related quality of life (HRQoL) was examined. Employment rates ranged from 4% to 50.4%. The studies differed considerably in design, patient settings, and methods of recruitment. The most frequently reported factors associated with employment were negative and cognitive symptoms, age of onset, and duration and course of the disease. Individual characteristics associated with unemployment were older age, lower education, and sex (female). Additionally, environmental factors, eg, the availability of welfare benefits and vocational support programs, seemed to play a role. Generally, being employed was positively associated with HRQoL. However, the causal direction of this association remained unclear, as studies on the bidirectional relationship between employment and HRQoL were lacking.

Entities:  

Keywords:  employment; environment; health-related quality of life; mental illness; patient characteristics; unemployment; work

Year:  2015        PMID: 26316759      PMCID: PMC4547637          DOI: 10.2147/NDT.S83546

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.570


Introduction

On a patient level, employment plays a central role in providing financial income and nonfinancial gains, including social identity, social contacts and support, a means of structuring and occupying time, activity and involvement, and a sense of personal achievement.1 People with long-term mental illness, including schizophrenia, are sensitive to the negative effects of unemployment, and experience barriers to work, due to stigma, prejudice, and discrimination.1 Apart from these individual disadvantages, unemployment in people with schizophrenia is economically costly from a societal point of view. The estimated total societal cost of schizophrenia was 6.7 billion pounds in England for the year 2004–2005.2 Half of these costs were due to unemployment, absence from work, and premature mortality, amounting to 3.4 billion pounds. Studies reporting on employment in people with schizophrenia show diverging figures. However, generally employment rates are low. Marwaha and Johnson were the first authors to publish a review on schizophrenia and employment.3 They concluded that there is a wide variation in reported employment rates. Additionally, their study showed that employment is correlated with positive outcomes in social functioning, symptom levels, quality of life (QoL), and self-esteem, but a clear causal relationship was not demonstrated.3 Increasingly, treatment models have focused on the subject of employment in people with schizophrenia. These treatment models strive, among other goals, to increase the individual’s own subjective view of well-being and satisfaction with his or her life. This development is in line with the shift in mental health services from an emphasis on treatment focused on reducing symptoms, based on a narrow notion of health and disease, to a more holistic approach that takes both well-being and functioning into consideration.4 However, for people with schizophrenia, there is still a lack of information on the subject of employment and associated health-related QoL (HRQoL). A previous study has shown that being employed is associated with a markedly better HRQoL for people with schizophrenia.5 However, the relationship between being employed and HRQoL may be bidirectional. It is known that the type of employment plays a crucial role in the effect on HRQoL.5 For instance, having a voluntary job, in general, means a low income. This may result in relatively poor living conditions and inability to afford social activities. Consequently, this may lead to a diminished HRQoL.6,7 In addition, although intuitively being employed may lead to increased HRQoL, the converse reasoning is also defendable, that is, having a higher HRQoL indicates being happier, presumably resulting in better capacities to perform daily activities such as a (paid) job. So, there is still a need to further explore the association between employment and HRQoL in schizophrenia. Firstly, this review assessed the prevalence of employment in people with schizophrenia. Next, we aimed to identify factors associated with being employed in this population. Lastly, we examined the interrelation between being employed and HRQoL that was assessed in the studies under review.

Methods

A literature search was conducted to identify the employment rate in people with schizophrenia. We applied a broad definition of employment as having any job, whether full-time or part-time, and whether competitive or supported employment. In addition, we screened the selected papers for factors associated with being employed and for the interrelationship between being employed and HRQoL.

Search strategy

A systematic literature search was performed in PubMed and PsychInfo, including studies from 2000 until July 1, 2013, including information on employment in representative (groups of) adults diagnosed with schizophrenia. We applied a broad search strategy for identifying studies. Consequently, no criteria concerning study design were applied. The search terms included the Medical Subject Headings (MeSH) terms and Field terms “schizophrenia”, “employment”, “unemployment”, “paid work”, and “work capacity” (Supplementary material). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was followed for the reporting of systematic reviews and meta-analyses.8

Selection strategy

The selection of the abstracts was independently performed by two researchers. Discrepancies concerning inclusion or exclusion of an abstract were resolved by discussing the eligibility criteria during plenary meetings. The selection criteria were: Studies published in 2000 or later Studies performed in Western countries, or in Japan or Hong Kong Studies explicitly including people diagnosed with schizophrenia Studies for which information on (un)employment or work was given in the Abstract Case studies, editorial letters, comments, or conference proceedings were excluded Studies reporting on vocational rehabilitation therapy and/or vocational support programs were excluded. To determine the eligibility of the full-text articles, the same selection criteria were used. Additional exclusion criteria were: Duplication of source data (ie, studies using samples of other included studies were excluded) Unavailability of the full-text publication Studies including selective samples, eg, the homeless, the convicted, or convenience samples, were excluded Studies including study samples with <100 participants. First, we presented the prevalence rates of employment in people with schizophrenia, derived from the review. In order to systematically describe the factors associated with employment, a simplified framework was used based on the model of Wilson and Cleary,9 which integrates health aspects with functional status and HRQoL. The basic domains of functional status that are commonly measured are physical”, “social”, “role”, and “psychological functioning”.10 We defined being employed (or unemployed) as part of the functional status. The symptoms are reflected in the disease characteristics of the disorder – these may reflect physical impairment as well as patients’ emotional or cognitive state. Schizophrenia can be described as a syndrome11,12 characterized by: Positive symptoms Negative symptoms Cognitive symptoms Affective symptoms. Symptoms of schizophrenia are generally described in terms of a positive and a negative dimension. The Positive and Negative Syndrome Scale (PANSS) is, among other instruments, applied for measuring the severity of positive and negative symptoms.13 Positive symptoms indicate the occurrence of delusions and hallucinations, while negative symptoms indicate lack of motivation, reduction in spontaneous speech, and social withdrawal. Additionally, there may be a cognitive dimension (difficulties in memory, attention, and executive functioning) and a dimension of affective dysregulation (depression and manic symptoms). Additionally, the disorder can be described in terms of the age at onset of the disease, the treatment setting, and the duration and course of the disease in terms of remission. Finally, the functional status may be affected by the co-occurrence of substance and alcohol abuse. Substance abuse has been found to be substantially more prevalent among people with schizophrenia.14,15 However, prevalence rates of co-occurring dependence or abuse in people with schizophrenia may vary between countries.16 Substance abuse may worsen the impact of schizophrenia, leading to heightened social adjustment problems.17 The adapted model takes into account that characteristics of the individual as well as “characteristics of the environment” might impact the experience of symptoms, functional status, and HRQoL, and their relationships. Examples of individual characteristics are age, sex, personality, and individual expectations. With regard to being employed, specifically, motivation and “work readiness” are examples of characteristics of the individual that are probably of importance in finding and maintaining a paid job. Examples of environmental characteristics are social and vocational support, and social security programs. Finally, stigma is also a factor known to diminish the HRQoL of people with schizophrenia, even after recovery of the person.18 Overall QoL is preferably measured with a generic preference based instrument. In this way, the impact of a condition on HRQoL can be assessed in terms that are relevant to any individual.

Data extraction

Employment rates from the publications were independently extracted by two researchers. Additional data that were collected were the design of the study, the country, the sample size, exclusion criteria, the study setting, demographic information of the study population, clinical measures (eg, PANSS), length of illness, and comorbidity. Additionally, findings concerning associations with employment and concerning employment and HRQoL were recorded.

Results

A total of 789 records were derived from the databases. After removal of duplicates, 701 abstracts were screened. In the search, six review studies were identified. Studies cited in these reviews that were not identified in our search and that met our selection criteria were added (Figure 1).
Figure 1

Flow chart of the literature search.

Notes: Reasons for exclusion: 2= not performed in a Western country or Japan or Hong Kong; 3= people with schizophrenia not explicitly included; 4= no (un)employment rate described; 5= case study; 6= study on vocational rehabilitation therapy or vocational support programs; 7= duplicate sources; 8= full text publication unavailable; 9= studies including selective samples or convenience samples were excluded; 10= study sample had <100 subjects.

In total, 43 studies were eligible for analyzing the prevalence of employment (Table 1).
Table 1

Studies reporting on employment in people diagnosed with schizophrenia

AuthorStudy designNCountrySingle/multicenterExclusion criteriaIn-/outpatientsStudy population characteristicsEmployed (%)Remark
Abdel-Baki et al19Cohort Baseline + FUBaseline: n=142; 2-yr FU: n=111; 5-yr FU: n=97; 10-to 16-yr FU: n=78; 5-yr FU: n=78CanadaMulticenterSchizoaffective and other psychotic disordersIn-and outpatientsBaseline: Age (median): 24.4 yrsMales: 71.1%Length of illness: close to illness onsetAlcohol/substance abuse: 27.5% (at some point)PANSS: NRBaseline: 20.1%; 2-yr FU: 14.9%; 5-yr FU: 22.6%; 10-to 16-yr FU: 17.9%Employment not specified
Alonso et al20Cohort Baseline9,340Denmark, France, Greece, Ireland, Italy, the Netherlands, Portugal, Spain, UKMulticenterNROutpatientsAge (mean): 40 yrsMales: 57.9%Length of illness: 11.3 yrsAlcohol/substance abuse: NRPANSS: NR19.7%Paid employment, not further specified
Ascher-Svanum et al21Cohort Baseline + 3-yr FU2,175USAMulticenterNRNRBaseline: Age (mean): 42.1 yrsMales: 61.4%Length of illness: 21.6 yrsAlcohol/substance abuse: 27.1%PANSS neg: 18.3PANSS pos: 16.1Baseline: 21.1% 3-yr FU: 21.5%Paid employment, not further specified
Barbui et al22RCT Baseline409UK, Italy, the Netherlands, GermanyMulticenterTreatment by forensic psych services, alcohol/drug dependence, moderate/severe mental handicapNR. Probably outpatientsAge (mean): 41.5 yrsMales: 59.9%Length of illness: NRAlcohol/substance abuse: NRPANSS: NRUnemployed 44.7%Not specified
Bobes et al23Cross-sectional Baseline1,452SpainMulticenterNROutpatients receiving commonly used oral antipsychotic treatmentAge (mean): 40.7 yrs (range 18–74 yrs)Males: 60.9%Length of illness: 15.5 yrsAlcohol/substance abuse: NRPANSS neg: 20.6PANSS pos: 14.8Active 19.8%Sick leave 6.1%Disability pension 47.5%; unemployed 17%Employment not specified
Boyer et al24Cross-sectional Baseline113FranceSingle-centerMental retardation, unstable condition 2 months before inclusionOutpatientsAge (mean): 38.6 yrsMales: 69.9%Length of illness: 13.9 yrsAlcohol/substance abuse: NRPANSS: NR14.2%Employment not specified
Caron et al25Cohort Baseline181CanadaMulticenterPhysical illness, neurological disorders; acute symptoms; treatment through mental health services <2 yrsOutpatients + probably <10% inpatientsAge (mean): 40.3 yrsMales: 76%Length of illness: NRAlcohol/substance abuse: NRPANSS: NR7.2%Patients with income from paid employment
Cechnicki et al26Cross-sectional Baseline202PolandMulticenterPresence of acute symptomsIn-and outpatientsAge (mean): 39.9 yrsMales: 49%Length of illness: NRAlcohol/substance abuse: NRPANSS: NR2% full time; 5.4% part timeSheltered job 5%; pension/disability 68.3%Employment not specified
Chwastiak et al27RCT Baseline1,424USAMulticenterFirst episode or history of only 1 episode; unstable medical condition, treatment refractory/resistance, schizoaffective disorder, mental retardation/other cognitive disorder; cardiac disordersBoth inpatients and outpatientsAge (mean): 40.6 yrsMales: 75%Length of illness: NRAlcohol/substance abuse: NRPANSS neg: 20.1PANSS pos: 18.426% Earned income 14%; other vocational activity 12%Employment rate = earned income or noncompetitive employment activities (volunteer work; workshop; prevocational programs)
Compton et al28Cross-sectional survey Baseline248USAMulticenterOther diagnoses than schizophrenia, schizophreniform disorder and schizoaffective disorder were excludedIn-and outpatientsAge (mean): 42.9 yrsMales: 64.3%Length of illness: NRAlcohol/substance abuse: 27.4%PANSS: NRNot working: 83%Not further specified
Cuyún Carter et al29Cross-sectional Baseline1,635USAMulticenterParticipating in clinical drug trial within 30 days prior to enrollmentIn-and outpatients (93.5%)Age (mean): 42.3 yrsMales: 61.2%Length of illness: NRAlcohol/substance abuse: 26.3%PANSS neg: 18.3PANSS pos: 18.520.6%Employment not specified
Giugiario et al30Cross-sectional253ItalySingle-centerClinical unstable. Patients with other employment than competitive were excludedOutpatientsAge (mean): 40.1 yrsMales: 57.9%Length of illness: 14.3 yrsAlcohol/substance abuse: NRPANSS neg: 19.6PANSS pos: 14.530.0%Competitive employment: Job paid min wage or higher, not contracted with a social service agency
Gureje et al31Cross sectional582AustraliaNRNR (Sample derived from data of the Australian National Survey of Mental Health and Wellbeing)In-and outpatientsAge (mean): 38.7 yrsMales: 66.5%Length of illness: 14.8 yrsAlcohol/substance abuse: NRPANSS: NRUnemployed: 76.3%; On disability/sickness pension 79%No definition reported
Hansson et al32RCT507Spain, the Netherlands, UK, Sweden, Germany, SwitzerlandMulticenterNo severe organic psychiatric illness or primary substance abuseOutpatientsAge (mean): 42.2 yrsMales: 66.2%Length of illness:15.9 yrsAlcohol/substance abuse: NRPANSS: NRUnemployed 36.0%Not specified
Henry et al33Cohort FU (mean FU 6.9 yrs)361AustraliaSingle-centerDrug-/alcohol-induced psychosisIn-and outpatientsBaseline: Age (mean): 21.9 (baseline range 14–30 yrs)Males: 77%Length of illness: NRAlcohol/substance abuse: NRPANSS neg: NRPANSS pos: NR36.3% (part time or full time) Unemployed/Government benefits 57.6%Employment not specified
Hofer et al34Cross sectional140AustriaMulticenterClinical unstable; suffering from any other axis I disorder, including substance abuseOutpatients disordersAge (mean): 40.2 yrsMales: 60%Length of illness: 11.2 yrsAlcohol/substance abuse: 0%PANSS neg: 15.7PANSS pos: 11.28.6% (full time) 7.1% (part time) Supported employment 12.1%; training 7.9%; unemployed 65.7%Competitive employment
Holthausen et al35Cohort 2-yr FU103the NetherlandsMulticenterSevere mental retardation, systemic or neurological illnessNRBaseline: Age (mean): 23.6 yrsMales: 74.8%Length of illness: onset within 2 yrs before inclusionAlcohol/substance abuse: 68%PANSS: NR20.4%Competitive employment or studying with a scholarship
Honkonen et al36Cohort 3-yr FU2,168FinlandMulticenterNR. Included 3 cohorts of persons with schizophrenia 3 years after discharge from psychiatric hospital (discharged 1986, 1990, and 1994). Representing patients with long-term schizophreniaNRAge (mean): 39.2Males: 66.5%Length of illness: NRAlcohol/substance abuse: NRPANSS: NROverall after 3 yrs: 4%Part-time or full-time competitive employment (including self-employed, farmers, farmers’ wives)
Karadayi et al37Cross-sectional102TurkeySingle-centerHospitalized/having relapse within the last 3 months; severe physical disorderOutpatientsAge (mean): 31.5 yrsMales: 59.8%Length of illness: 9.9 yrsAlcohol/substance abuse: 2%PANSS neg: 13.0PANSS pos: 11.237.3%Employment was a part-time or full-time working activity with payment or attending school
Kulkarni et al38Cohort Baseline + 3-yr FU347 276AustraliaMulticenterNRIn-and outpatientsBaseline: Age (mean) age: 33.8 yrsMales: 62%Length of illness: NRAlcohol/substance abuse: NRPANSS neg: 18.3PANSS pos: 16.7Baseline: 11% 3-yr FU 16%Paid employment, not further specified
Lambert et al39Cohort Baseline2,960GermanyNRBipolar disorder, substance induced psychosis or psychosis due to medical conditionOutpatientsAge (mean): 42.3 yrsMales: 49.4%Length of illness: NRAlcohol/substance abuse: 19.7%PANSS: NR42.6%Full or part time (not further specified) or attending school/university
Mackell et al40Cross-sectional332USANRNRNR. Probably outpatientsAge (mean): 39.6 yrsMales: 72.6%Length of illness: NRAlcohol/substance abuse: 5%PANSS: NR20.5%Paid employment, not further specified
Marwaha et al41Cohort 2-yr FU1,086UK, Germany, FranceMulticenterContinuously in hospital for the previous 12 months; currently homelessNRRefer to Marwaha et al4227.3%Full-or part-time jobs, including sheltered employment and voluntary work
Marwaha et al42Cross-sectional Baseline1,208France, Germany, UKMulticenterContinuously in hospital for the previous 12 months; currently homelessNRAge (mean): 40.8Males: 61.5%Length of illness: 14.4Abuse: alcohol 2.9%; substance 1.1%PANSS neg: 15.8PANSS pos: 12.421.5% (never employed 7.9%)Full-or part-time jobs, including sheltered employment and voluntary work
Mausbach et al43Cross-sectional Baseline367USANRNR (patients with Jewish background participating in genetic studies)Outpatients or patients in residential treatment setting (10.6%)Age (mean): 50.5 yrs (range 21–78 yrs)Males: 62.9%Length of illness: NRAlcohol/substance abuse: NRPANSS neg: 16.1PANSS pos: 15.631.9% (sheltered employment 7.1%)Employed is nonsheltered job for at least 20 hr per week
McCreadie44Cross-sectional316ScotlandMulticenterNRIn-and outpatientsAge (mean): 45 yrsMales: 62%Length of illness: 8 yrsAbuse: alcohol 20%/substance 16%PANSS: NR8%Paid employment, not further specified
Mechanic et al45Cross-sectional320USAMulticenterNR. Data were derived from the National Health Interview survey on disability 1994/95OutpatientsAge (mean): NRMales: NRLength of illness: NRAlcohol/substance abuse: NRPANSS: NREmployed 22.5% (CI: 18%–27%) (full-time employed) (≥35 hr) 12% (CI: 8%–16%)Employed: have been working in the past 2 weeks and not laid off
Middelboe et al46Cross-sectional418Denmark, Sweden, Norway, Finland, IcelandMulticenterNR. (incl duration of ≥1 year since diagnosed; aged 25–55 years at inclusion; noninstitutional living situation)OutpatientsAge (mean): 39 yrsMales: 65%Length of illness: 15 yrsAlcohol/substance abuse: NRPANSS: NR12%Employment not specified
Mueser et al47RCT Baseline + FU313USAMulticenterCurrent/recent dependence on alcohol or drugs. Not willing to take fluphenazine decanoate injectionsNR. Probably outpatientsMean age: 29.6 yrs (range 19–55)Males: 66.1%Length of illness: NRAlcohol/substance abuse: 0%PANSS: NRBaseline: 9.7% (+6.8% other vocational activity, incl sheltered work, volunteer, vocational training, and casual labor) 1-yr FU: 23.3 2-yr FU 21.0Competitive employment
Ramsay et al48Cross-sectional181USAMulticenterNo history of outpatient treatment for psychosis or prior hospitalization for psychosis more than 3 months before the admissionInpatients at inclusion Aged 18–40 yrsAge (mean): 23.36 yrsMales: 74%Length of illness: NRAlcohol/substance abuse: 55.3%PANSS neg: 21.3PANSS pos: 23.8Unemployed 65%Unemployed during month prior to hospitalization
Resnick et al49RCT Baseline1,121USANRNRNRAge (mean): 41Males: 73.8%Length of illness: NRAbuse: alcohol 6.5%/substance 10%PANSS neg: 20.25PANSS pos: 18.3Full time 7.8% part time 10.2%Paid employment Whether competitive, transitional or sheltered
Rosen and Garety50Cohort Baseline394UKMulticenterIQ <70, drug/alcohol abuse as primary problemIn-and outpatientsAge (mean): 28.8 yrs (range 16–45)Males: 58.4%Length of illness: NRAlcohol/substance abuse: 22.8% (current or earlier)PANSS: NR41.2% Students 11.6%
Slade and Salkever51Cohort Baseline1,643USAMulticenterNRNR. Probably in and outpatientsAge (mean) age: 42 yrs (range 18–78)Males: 63%Length of illness: NRAlcohol/substance abuse: NRPANSS: NR21.8% (11.6% nonsupported jobs 10.2% in sheltered or supported jobs)Working for pay in last 4 weeks
Spellmann et al52Cohort Baseline + 1-yr FU211GermanyMulticenterMajor medical illness; alcohol or drug dependencyBaseline: treated as inpatients FU: probably all outpatients(1-yr FU)Age (mean): 36.6 yrsMales: 52.6%Length of illness: 8.0 yrsAlcohol/substance abuse: 0%PANSS neg: 14.81PANSS pos: 10.46Baseline: 50.4% (unemployed 29.8%, retired 19.8%)1-yr FU43.1% (unemployed 34.1%; retired 16.1%)Employment not specified
Thornicroft et al53Cross-sectional404the Netherlands, Denmark, UK, Spain, ItalyMulticenterCurrent residence in prison, secure residential services or hostels for long-term patients, mental retardation, dementia or severe organic disorder, extended inpatient treatment episode >1 yrNR. Probably in and outpatientsAge (mean): 41.8 yearsMales: 57%Length of illness: NRAlcohol/substance abuse: NRPANSS: NR17%, sheltered work 4%Employment (not specified) or student, sheltered work excluded
Thorup et al54RCT Baseline388DenmarkMulticenterPatients with psychiatry symptoms due to organic conditionNRAge (mean): NRMales: 60.6%Length of illness: NRAlcohol/substance abuse: 30.7%PANSS: NR19.6%Job or education during the whole preceding year
Üçok et al55Cross-sectional Baseline295France, Belgium, Germany, Israel, Italy, Spain, Sweden, Turkey, UKMulticenterNRNRAge (mean): 43.7 yearsMales: 44.7%Length of illness: NRAlcohol/substance abuse: NRPANSS neg: 20.7PANSS pos: 16.917.2% (unemployed 65.7%)Employed: working in full-time or part-time paid job (students excluded)
Usall et al56Cohort Baseline239SpainMulticenterPrimary diagnosis of alcohol/drug abuse; mental retardation; neurological disease or head traumaOutpatientsAge (mean): 38.9 yrsMales: 64%Length of illness: 16.8Alcohol/substance abuse: NRPANSS neg: 26.1PANSS pos: 14.427.2%Employment not specified
Uzun et al57Cohort Baseline116TurkeySingle-centerConcomitant neurological or organic brain syndrome or diagnosed with brief drug-related psychosesOutpatientsAge (median): 59 yrsMales: 54.2%Length of illness: NRAlcohol/substance abuse: 5.2%PANSS: NR9.5% (students: 4.3%; unemployed: 86.2%)Employment not specified
Waghorn et al58Cross-sectional385AustraliaNALong stay hospital inpatients (≥9 weeks)In-and outpatientsAge (mean): NRMales: 66.5%Length of illness: NRAlcohol/substance abuse: 43.1% (lifetime)PANSS: NREmployed 15.8% Unemployed, studying or retired: 84.2%Employment part time or full time, not further specified
West et al59Cross-sectional Baseline151USAMulticenterNRNRAge (mean): NRMales: 66%Length of illness: NRAlcohol/substance abuse: 18%PANSS: NR20% (full-or part-time) Unemployed due to disability 75% Other(including students, retired) 5%Employment not specified
Xie et al60RCT of care management Baseline + FU152USAMulticenterNR Note: This is a selective sample (dual diagnosis: schizophrenia or schizoaffective disorder and co-occurring substance abuse/dependence)In-and outpatientsBaseline: Age (mean): 32.4 yrsMales: 77.6%Length of illness: NRAlcohol/substance abuse: Alcohol 82.7%; cannabis 45%; cocaine 15.2%; other drugs 17.2%PANSS: NRBaseline: 6%; FU 1 yr: 14%; FU 2 yrs: 15%; FU 3 yrs: 24%Competitive job in preceding year, not further specified
Ye et al61Cohort Baseline + 1-yr FU258JapanMulticenterPatients not treated with risperidoneIn-and outpatientsAge (mean): 42 yrsMales: 49.2%Length of illness: 14.1 yrsAlcohol/substance abuse: NRPANSS: NRBaseline: overall 9.4%; (outpatients 15.1% inpatients 2.6%) 1-yr FU: 14.4% (outpatients 21.3%; inpatients 6.5%)Employment is working for pay

Abbreviations: CI, confidence interval; FU, follow up; IQ, intelligence quotient; NR, not reported; PANSS, positive and negative syndrome scale; RCT, randomized controlled trial; hr, hour; incl, including; pos, positive; neg, negative.

Employment rate

Employment rates ranged from 4% to 50.4%.36,52 Generally, employment rates reported in the studies were based on different definitions of employment, eg, the employment in some studies was limited to competitive employment, while in other studies, respondents with supported or sheltered employment were counted too, and in a number of studies, students and/or housewives and those who had volunteer work were also counted as being employed. Additionally, in a number of studies, the definitions of employment that were applied were not reported. Five studies reported only unemployment figures. The studies differed considerably in design, patient settings, and methods of recruitment. Information on the time frame that was used for measuring employment was generally lacking. In the majority of studies, no distinction was made between respondents with schizophrenia, and schizophreniform or schizoaffective disorders. In addition, respondents may have been diagnosed on the basis of different criteria. This fragmented information limited a direct comparison of employment rates reported in these studies. Consequently, these results did not allow performance of a meta-analysis for estimating an average employment rate among people with schizophrenia.

Factors associated with employment

Disease characteristics

Positive symptoms

Marwaha et al41 examined employment status change during a 2-year European naturalistic study of people with schizophrenia. The researchers found that more positive psychotic symptoms were predictive of job loss.

Negative symptoms

Our review included three studies that reported on associations of negative symptoms and employment. Üçok et al55 reported significantly higher PANSS negative symptoms scores in unemployed respondents in comparison with employed respondents. In addition, regression analyses showed that the PANSS negative symptoms score was an independent predictor of unemployment. Bobes et al23 found that presence of poor rapport and social withdrawal (items of negative PANSS) increased the risk of unemployment. Marwaha et al41 found that besides characteristics of the onset and duration of the disorder, more severe negative symptoms (PANSS subscale) were significantly negatively associated with the chance of getting work during a 2-year follow-up study.

Cognitive symptoms

Associations of cognitive symptoms and employment were reported in three studies in our review. Giugiario et al30 reported significantly higher scores of verbal memory and more awareness of illness in respondents with competitive employment in comparison with unemployed subjects. In a longitudinal study, Holthausen et al35 found more problems of vocational functioning and significant lower chances of competitive employment in persons with cognitive deficits. Hofer et al34 found that poorer cognitive scores were associated with a reduced probability of competitive employment.

Treatment setting

Another, more indirect indicator of disease severity may be the setting in which people receive care, ie, in-or outpatient care. Most studies included both in-and outpatient treated people. A number of studies did not provide information on the treatment setting. Ten studies included only persons treated in an outpatient setting. Employment rates varied considerably, from 9.5% to 42.6%. No study was found exclusively focusing on inpatients. Only in the study of Ye et al61 were figures of employment rates for in-and outpatients separately presented. Both the baseline and follow-up employment rates in persons treated as outpatients were almost four times higher in comparison with the rates among inpatients.

Age at onset, course, and duration

Marwaha et al examined predictors of being employed during a 2-year follow-up, using cross-national data derived from Germany, France, and the UK.41 Later age of illness onset, longer duration of illness, and a continuous illness course were negatively associated with the chance of getting work. Üçok et al reported significantly higher remission rates among employed subjects in comparison with unemployed subjects, and longer duration of remission contributed positively to employment status.55 Fourteen studies in our review reported on the duration of the illness.20,21,23,24,30,34,36,37,42,44,46,52,56,61 A comparison of the employment rates and the duration of the disorder between these studies did not show a consistent pattern of declining rates with longer duration of the disorder. For example, McCreadie44 reported an employment rate of 8% in study participants, with an average duration of 8 years, while Middelboe et al46 reported an employment rate of 12% in participants, with an average duration of 15 years.

Alcohol and substance abuse

In the study of Marwaha et al harmful use of alcohol at baseline was a significant predictor of job loss during a 2-year follow up.41 In our review, 22 studies included information about the proportion of respondents with alcohol or substance abuse. The study of Xie et al60 included only patients with co-occurring substance abuse. The employment rate was 6% at baseline and increased to 24% at 3-year follow up. In three studies, respondents with alcohol/substance abuse were excluded.34,47,52 Employment rates reported in these studies were 43.1% (1-year follow up), 27.8% (baseline), and 23.3% (1-year follow up), respectively. The figures presented in these studies are difficult to interpret given the different definitions of employment in these studies. In addition, in the study of Spellmann et al52 no definition of employment was stated.

Characteristics of the individual

Marwaha and Johnson3 reported on a number of demographic factors related to being employed in people with schizophrenia in their review, eg, sex, and marital and accommodation status. However, the authors reported that these associations were not consistently replicated between different studies. Among the studies in our review, Üçok et al55 found that younger age, more education, and sex (male) were independent positive predictors of employment. Hofer et al34 found that premorbid school functioning was positively correlated with competitive employment, and older age was found to be a significant negative predictor of employment.

Characteristics of the environment

Studies that examined environmental factors and the subject of employment were limited. Marwaha et al42 conducted a study to compare employment patterns and associated environmental factors between and within three European countries: UK, France, and Germany. Variation in employment rate was found both between countries and between regional sites. The greatest variation was found on the national level, between centers rather than between countries. The authors suggested that social and vocational service factors within and between countries may contribute to this variation. One of these factors may be the availability of vocational services and placements, as was seen in Germany. In two other studies that were performed in Germany, relatively high employment rates were reported.39,52 The low employment rate among people with schizophrenia in the UK reported by Marwaha et al42 and Thornicroft et al53 was not confirmed by the study by Rosen and Garety.50 In the latter study, an employment rate of 41.2% (excluding 12% students) was reported. In the study of Thornicroft et al53 including patients from five different European countries, relatively higher employment rates were found in southern countries (Spain and Italy) in comparison with Denmark and the Netherlands. The authors suggested that differences may be associated with differences in the availability of welfare benefits. Comparative low employment rates (12% in outpatients) in Scandinavian countries were also reported by Middelboe et al.46 In line with these findings, Giugiario et al30 reported a competitive employment rate of 30% in people with schizophrenia treated in an outpatient setting in Italy. Comparable figures were reported for outpatients in Spain (25.9% respectively 27.2%).23,56 Two studies were performed in Turkey.37,57 In the study of Karadayi et al37 employment was 37.3%. However, the employment rate, including students, reported by Uzun et al57 was substantially lower (13.8%). This may partly be explained by the relatively older sample of the study population (median age 59 years).

HRQoL

In total, 12 studies were found that investigated the HRQoL of people with schizophrenia. Eight studies20,24,25,53,62–65 used a disease-specific HRQoL instrument: the Subjective Quality of Life (S-QoL) (one study), Heinrichs–Carpenter Quality of Life (QoL) scale (three studies), Lancaster Quality of Life Profile (two studies), and Lehman’s Quality of Life Interview (QOLI) (two studies). Just one of the studies a generic HRQoL instrument was applied the Wisconsin Quality of Life Index (W-QLI) scale,25 and two studies applied a generic preference-based instrument (EQ-5D™ and Quality of Wellbeing).20,64 In nine of the 12 studies, the relationship between employment and HRQoL was studied (Table 2). All but one of the studies found a positive relationship between being employed and HRQoL. In the study by Xie et al60 which applied Lehman’s QOLI instrument, a nearly significant relationship (P=0.05) was established.
Table 2

Employment and health-related quality of life

AuthorCross-sectional design (Y/N)NCountryIn/outpatientsMulti/single-centerHRQoL instrumentType of HRQoL instrumentResult on relationship employment-HRQoL
Alonso et al20Y (cohort at baseline and follow-up)9,340EuropeOutpatientsMulticenterEQ-5D™Generic, preference-basedBaseline utility scores were significantly higher (P<0.0001) for patients with paid employment compared with patients without. Also, paid employment was associated with greater improvement in utility score in the first and third year after treatment with antipsychotics
Boyer et al24Y113FranceOutpatientsSingle-centerS-QoL 18Disease-specific (for patients with schizophrenia)Significant relationship between being employed and psychological well-being (based on multiple linear regression analysis)
Caron et al25Y (cohort at baseline)181CanadaOutpatients + probably <10% inpatientsMulticenterWisconsin QoL Index (CaW-QLI)Generic, descriptiveEmployed clients had higher QoL scores on the domains of physical health, social relation and support, and a higher global QoL score
Eklund et al62Y74SwedenOutpatientsSingle-centerLancashire Quality of Life ProfileDisease-specific (for patients with severe psychiatric disorders)Employed people had a significant better interviewer-rated HRQoL, self-rated HRQoL, and self-esteem
Marwaha et al63Y1,208EuropeMulticenterLehman’s QOLIDisease-specific (for persons with severe mental illness)Employment status was significantly associated with subjective QoL score (B=0.18, P=0.002)
Palmer et al64Y82USAInpatientsQWBGeneric, preference-basedQWB total score was significantly correlated with being historically employed (r=0.27, P<0.05)
Rosenheck et al65Y (cohort at baseline)1,424USAIn-and outpatientsMulticenterHeinrichs-Carpenter QoL ScaleDisease-specific (for patients with schizophrenia)Patients with competitive paid employment scored significantly higher (P<0.0001) on all domains of the QLS than did patients with other or no vocational activity On the domains “instrumental activity” and “object/activity”, patients with competitive employment scored higher than did patients in other kinds of employment who, in turn, scored higher than those not working
Thornicroft et al53Y404EuropeNR probably in and outpatientsMulticenterLancashire Quality of Life ProfileDisease-specific (for patients with severe psychiatric disorders)Having work is a significant predictor of subjective HRQoL (not specified)
Xie et al60Y (QoL and employment at follow-up treatment study)152USAIn-and outpatientsMulticenterLehman’s QOLIDisease-specific (for persons with severe mental illness)No significant correlation (P=0.05) was found between QOLI-general life satisfaction score and having a competitive job in the past year

Abbreviations: CaW-QLI, the Wisconsin Quality of Life Index-Canadian version; HRQoL, health-related quality of life; NR, not reported; QLS, quality of life scale; QoL, quality of life; QOLI, quality of life interview; QWB, quality of wellbeing; S-QoL, subjective quality of life.

Discussion

Our review study showed that employment rates in people with schizophrenia vary between 4.5% and over 50%. There were significant differences between the definitions of employment that were applied in the studies. Nevertheless, unemployment figures are even more difficult to interpret, since these rates may refer to only those looking for work, while other rates may include respondents with long-term disability benefits or pensions. The comparison of employment rates between studies is further limited by differences in study designs, recruitment methods, diagnostic instruments, clinical variables reported, and different time frames for measuring employment. However, generally, employment in people with schizophrenia is relatively low, as was reported in the study of Marwaha et al.42 In that study, employment rates were presented for people with schizophrenia in the UK (12.9%), France (11.5%), and Germany (30.2%) in comparison with employment rates in the general population of these countries (of 71.0%, 62.2%, and 65.4%, respectively). Due to the methodological differences between the studies, we were unable to make a valid estimation of an average employment rate. In addition to employment rates, we screened the papers on factors associated with employment, including the association of employment and HRQoL. The most frequently reported disease characteristics that were negatively associated with employment were negative symptoms and cognitive symptoms. This is in line with the earlier findings reported by of Marwaha and Johnson.3 Additionally, later age of disease onset, and the duration and continuous course of the disease may play a role in employment status of the person. Finally, employment rates were higher in people treated in an outpatient setting in comparison with rates among inpatients. It is not clear to what extent this finding is related to the severity of the disease. Both individual and environmental characteristics were found to be associated with employment rates. Individual characteristics associated with unemployment were (older) age, lower education, and sex (females). Additionally, employment rates were associated with a number of environmental factors. The large variation of employment rates between countries or regions seem to indicate that environmental characteristics, such as the availability of welfare benefits and the availability of vocational services and sheltered employment, may play an important role. Employment rates seem to be lower in countries with an increased level of social security, as was reported in the study of Thornicroft et al.53 Relatively higher employment rates were generally found in studies performed in southern European countries. It can be assumed that these higher rates may be associated with dependence on the financial support of family members. These findings are in line with the study of Kilian and Becker, of the macroeconomic indicators of labor force participation of people with schizophrenia.66 In addition, they found a close relation between general employment rates and employment rates of people with schizophrenia. In another study, a negative association was found between competitive employment and receipt of disability payment. Van der Wel et al reports that studies on the association of nonemployment among people with limiting longstanding illness and differences in welfare policies show equivocal results.67 More research is recommended for assessing associations of welfare policy and employment in patients with severe mental illness. Several studies suggested that the availability of vocational service factors may contribute to employment in people with schizophrenia. Increased access to rehabilitation services was associated with participation in both competitive and noncompetitive employment.65 Generally, being employed and HRQoL were positively associated. A possible explanation for the association between being employed and HRQoL that was found in our review was indicated by Brekke et al68 who described self-esteem to be a mediating factor between being employed and HRQoL. A larger social network due to being employed, resulting in a better HRQoL, is being proposed as another potential explanation.25 Most studies applied a disease-specific HRQoL instrument. This seems in line with the current discussion about the validity of preference-based QoL instruments in people with schizophrenia. It is argued that generic preference-based instruments may not be appropriate for use in people with schizophrenia.69 The conceptual model of Wilson and Cleary was a helpful tool to describe the different factors associated with employment and HRQoL.9 The model has been widely applied to different patient populations.9 In the current review we found studies that reported on associations between disease characteristics, individual characteristics and environmental characteristics and employment. Another important question relates to the association between employment and HRQol. That is, while employment may increase QoL, it is likely that those with higher QoL are more likely to be employed. Currently, there is little literature adequately assessing the causal relationship between these two domains, leading to a methodological gap in the literature. A limitation of our study is that we focused our literature search primarily on employment rates rather than on factors associated with employment. Consequently, we did not perform separate searches for factors associated with employment. However, due to the broad approach that was applied for reviewing the literature, the number of missing studies is assumed to be limited. Finally, we excluded studies on Individual Placement and Support and other vocational support programs, as our primary goal was to assess the general employment rate in people with schizophrenia. Supported employment programs are evidence-based practices to enhance people with mental health disability to return to work. Employment rates of persons with schizophrenia included in supported employment trials may differ due to specific in-and exclusion criteria. In conclusion, our review showed a great variation in employment rates in people with schizophrenia. However, the overall employment rate was low. Employment rates varied widely across and within countries. Generally, there was a positive association between being employed and HRQoL. Importantly, however, the causal direction of this association remained unclear. When aiming to improve employment participation and associated HRQoL among people diagnosed with schizophrenia, symptoms, functional status, demographic characteristics of the population, and environmental factors should be taken into account. A better understanding of the interrelations of these components could lead to more integrated and personalized health management, and outcome optimization, for people with schizophrenia.

Supplementary material

(“schizophrenia”[MeSH Terms] OR “schizophrenia”[All Fields]) AND (“employment”[MeSH Terms] OR “employment”[All Fields]) OR (“unemployment”[MeSH Terms] OR “unemployment”[All Fields]) OR (paid[All Fields] AND (“work”[MeSH Terms] OR “work”[All Fields])) OR ((“work”[MeSH Terms] OR “work”[All Fields]) AND capacity[All Fields]) OR “efficiency”[MeSH Terms] OR “efficiency”[All Fields] OR “productivity”[All Fields]) OR (“absenteeism”[MeSH Terms] OR “absenteeism”[All Fields]) OR “presenteeism”[All Fields] OR (“occupations”[MeSH Terms] OR “occupations”[All Fields] OR “occupation”[All Fields]) AND ((hasabstract[text] AND “loattrfull text”[sb]) AND (“2000/01/01”[PDAT] : “2013/12/31”[PDAT]) AND humans”[MeSH Terms] AND English[lang] AND “adult”[MeSH Terms])
  68 in total

1.  Relationships between satisfaction with occupational factors and health-related variables in schizophrenia outpatients.

Authors:  M Eklund; L Hansson; U Bejerholm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2001-02       Impact factor: 4.328

2.  Employing persons with serious mental illness.

Authors:  David Mechanic; Scott Blider; Donna D McAlpine
Journal:  Health Aff (Millwood)       Date:  2002 Sep-Oct       Impact factor: 6.301

3.  Socio-demographic and clinical predictors of quality of life in patients with schizophrenia or schizo-affective disorder.

Authors:  Jean Caron; Céline Mercier; Pablo Diaz; Andrea Martin
Journal:  Psychiatry Res       Date:  2005-11-18       Impact factor: 3.222

4.  Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.

Authors:  Sandra G Resnick; Robert A Rosenheck; Jose M Canive; Cyril De Souza; T Scott Stroup; Joseph McEvoy; Sonia Davis; Richard S E Keefe; Marvin Swartz; Jeffrey Lieberman
Journal:  J Behav Health Serv Res       Date:  2008-02-02       Impact factor: 1.505

5.  The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

Authors:  Giuseppe Carrà; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Dirk Heider; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

6.  One-year functional outcomes of naturalistically treated patients with schizophrenia.

Authors:  Ilja Spellmann; Michael Riedel; Rebecca Schennach; Felix Seemüller; Michael Obermeier; Richard Musil; Markus Jäger; Max Schmauß; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Psychiatry Res       Date:  2012-03-14       Impact factor: 3.222

7.  Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes.

Authors:  Kate Rosen; Philippa Garety
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

8.  Predictors of psychiatrist-reported treatment-compliance problems among patients in routine U.S. psychiatric care.

Authors:  Michael T Compton; Bruce E Rudisch; Paul S Weiss; Joyce C West; Nadine J Kaslow
Journal:  Psychiatry Res       Date:  2005-10-11       Impact factor: 3.222

9.  Quality of life of clients with schizophrenia.

Authors:  Sally Chan; Iu Wai Yu
Journal:  J Adv Nurs       Date:  2004-01       Impact factor: 3.187

10.  Convergent validation of quality of life assessments for persons with severe mental illnesses.

Authors:  A F Lehman; L T Postrado; L T Rachuba
Journal:  Qual Life Res       Date:  1993-10       Impact factor: 4.147

View more
  26 in total

1.  Opinions and Expectations Related to Job Placement of Individuals with Schizophrenia: A Qualitative Study Including Both Patients and Employers.

Authors:  Yüksel Can Öz; Gül Ünsal Barlas; Mustafa Yildiz
Journal:  Community Ment Health J       Date:  2019-02-04

2.  Influence of Employment on the Positive Mental Health of Individuals with Schizophrenia Living in the Community.

Authors:  Eun-Young Na; Young-Jin Lim
Journal:  Psychiatr Q       Date:  2020-03

Review 3.  Clozapine in Reducing Aggression and Violence in Forensic Populations.

Authors:  Kathleen Patchan; Gopal Vyas; Ann L Hackman; Marie Mackowick; Charles M Richardson; Raymond C Love; Ikwunga Wonodi; MacKenzie A Sayer; Matthew Glassman; Stephanie Feldman; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2018-03

4.  Trial-Based Economic Evaluations of Supported Employment for Adults with Severe Mental Illness: A Systematic Review.

Authors:  Katherine Zheng; Brocha Z Stern; Q Eileen Wafford; Ciaran N Kohli-Lynch
Journal:  Adm Policy Ment Health       Date:  2022-01-17

Review 5.  Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.

Authors:  Irene Bighelli; Alessandro Rodolico; Spyridon Siafis; Myrto T Samara; Wulf-Peter Hansen; Salvatore Salomone; Eugenio Aguglia; Pierfelice Cutrufelli; Ingrid Bauer; Lio Baeckers; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2022-08-30

6.  Quality of Life in Patients with Chronic Psychotic Disorders: A Practical Model for Interventions in Romanian Mental Health Centers.

Authors:  Marinela Hurmuz; Mirela Frandes; Anca-Livia Panfil; Ileana-Pepita Stoica; Cristina Bredicean; Catalina Giurgi-Oncu; Ion Papava; Aurel Nirestean
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

Review 7.  Does Gender Influence Outcome in Schizophrenia?

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2019-03

8.  Quality of life, self-stigma, and coping strategies in patients with neurotic spectrum disorders: a cross-sectional study.

Authors:  Michaela Holubova; Jan Prasko; Marie Ociskova; Kryštof Kantor; Jakub Vanek; Milos Slepecky; Kristyna Vrbova
Journal:  Psychol Res Behav Manag       Date:  2019-02-01

Review 9.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

Review 10.  Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia.

Authors:  Myrto T Samara; Elisabeth Klupp; Bartosz Helfer; Philipp H Rothe; Johannes Schneider-Thoma; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.